Crossmark

C1-esterase Inhibitor Treatment is Associated with Immune and Vascular Pathway Modulation in PASC with Neurological Symptoms: Longitudinal Plasma Proteomics

Crossref DOI link: https://doi.org/10.1007/s10571-026-01736-4

Published Online: 2026-05-19

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Orr, Noga https://orcid.org/0000-0001-9631-3818
Collins, Maureen

Novak, Shawn

Melamed, Isaac

Steinman, Lawrence https://orcid.org/0000-0002-2437-2250
Funding

Funding for this research was provided by:

Pharming Healthcare Inc.
License Information

Text and Data Mining valid from 2026-05-19

Accepted Manuscript valid from 2026-05-19
More Information

Article History

Received: 5 September 2025

Accepted: 13 April 2026

First Online: 19 May 2026

Declarations

:

: N.O., M.C., S.N., and L.S. declare no conflicts of interest. I.M. reports receiving an educational grant from Pharming Healthcare, Inc.

Document is current

Any future updates will be listed below